J D Schwalm
Overview
Explore the profile of J D Schwalm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwalm J, Joseph P, Leong D, Lopez-Lopez J, Onuma O, Bhatt P, et al.
Lancet Reg Health Am
. 2025 Mar;
42:100964.
PMID: 40034111
While, many interventions can prevent cardiovascular disease (CVD), and its resulting morbidity or mortality, these are used sub-optimally in most countries. Therefore, health systems need to develop new approaches to...
2.
Jolly S, dEntremont M, Pitt B, Lee S, Mian R, Tyrwhitt J, et al.
N Engl J Med
. 2024 Nov;
392(7):643-652.
PMID: 39555814
Background: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is...
3.
Moxham R, dEntremont M, Mir H, Schwalm J, Natarajan M, Jolly S
CJC Open
. 2024 Nov;
6(10):1199-1206.
PMID: 39525334
Background: Prehospital transmission of the 12-lead electrocardiogram (ECG) to the interventional cardiologist has become the standard of care in many ST-elevation myocardial infarction (STEMI) networks but has not been adopted...
4.
Mir H, Cullen K, Mosleh K, Setrak R, Jolly S, Tsang M, et al.
JMIR Res Protoc
. 2024 Sep;
13:e55506.
PMID: 39240681
Background: Timely diagnosis and treatment for ST-elevation myocardial infarction (STEMI) requires a coordinated response from multiple providers. Rapid intervention is key to reducing mortality and morbidity. Activation of the cardiac...
5.
Schwalm J, Sheth T, Pinilla-Echeverri N, Petch J
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(3Part B):101305.
PMID: 39131228
No abstract available.
6.
Fuda M, Patel P, Van Es J, Mosleh K, Cullen K, Lonn E, et al.
CJC Open
. 2024 Apr;
6(2Part A):133-138.
PMID: 38585680
Because of the COVID-19 pandemic, several health care services, including cardiac rehabilitation (CR), had to transition to virtual delivery, for which formal evaluations are lacking. In this pilot study, we...
7.
Drakos A, McCready T, Lopez-Jaramillo P, Islam S, Mckee M, Yusuf S, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Mar;
17(4):e009342.
PMID: 38440889
Background: The HOPE 4 trial (Heart Outcomes Prevention and Evaluation 4) investigated the effectiveness of a comprehensive, collaborative model of care, implemented in Colombia and Malaysia, which aimed to reduce...
8.
Schwalm J, Walli-Attaei M, Yusuf S
JAMA Netw Open
. 2023 Jan;
6(1):e2251162.
PMID: 36656588
No abstract available.
9.
Schwalm J, Ivers N, Bouck Z, Taljaard M, Natarajan M, Nguyen F, et al.
BMC Med
. 2022 Jun;
20(1):213.
PMID: 35725542
Background: Preliminary evidence suggests that providing longer duration prescriptions at discharge may improve long-term adherence to secondary preventative cardiac medications among post-myocardial infarction (MI) patients. We implemented and assessed the...
10.
Jezrawi R, Balakumar S, Masud R, Gabizon I, Bhagirath V, Varughese J, et al.
Digit Health
. 2022 Jun;
8:20552076221102773.
PMID: 35646382
Objective: Factors that physicians and patients consider when making decisions about using or recommending health apps are not well understood. We explored these factors to better assess how to support...